Staff Profile
Career Summary
Biography
Dr Gough Au is a conjoint Post Doctoral Research Fellow with the University of Newcastle and works for the Australian oncolytic virotherapy company Viralytics Ltd. Dr Au began his career as a NHMRC Industry Research fellow (2007-2011) carrying out research on the development of naturally occurring viruses with selective anti-cancer properties, for the treatment of melanoma, multiple myeloma and malignant glioma.
Qualifications
- PhD, University of Newcastle, 13/09/2005
- Bachelor of Biomedical Sciences (Hons), University of Newcastle, 14/12/2000
- Bachelor of Biomedical Sciences, University of Newcastle, 02/12/1999
Research
Research keywords
- Carcinogenesis
- Clinical sciences
- Oncology
- oncolytic virotherapy
- virology
Research expertise
Oncolytic virotherapy, Virology & Cancer Biology
Languages
- English
Fields of Research
| Code | Description | Percentage |
|---|---|---|
| 110300 | Clinical Sciences | 35 |
| 030499 | Medicinal And Biomolecular Chemistry Not Elsewhere Classified | 35 |
| 111299 | Oncology And Carcinogenesis Not Elsewhere Classified | 30 |
Appointments
| Fellowship National Health & Medical Research Council (Australia) | 01/05/2007 - 01/04/2011 |
Collaboration
Gough's main research interest is in the development of naturally occurring viruses with selective anti-cancer properties, for the treatment of melanoma, multiple myeloma and malignant glioma. Other interests include Oncolytic virotherapy, Virology and Cancer Biology.
Administrative
Administrative expertise
Animal Care and Ethics Committee member (2011- to present)
Faculty of Health - Work Health and Safety Group
Teaching
Teaching expertise
PHAR6124 Virology Lectures
HUBS3204 Lab Professional Skills - Commercialisation of Science and Biotechnology Startup Companies
Grants and Funding
Summary
| Number of grants | 9 |
|---|---|
| Total funding | $595,774 |
For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.
Click on a grant title below to expand the full details for that specific grant.
2011 (3 grants)
Maitland Cancer Appeal Committee Donation - Lung Cancer Mouse Model$50,000
Funding Body: Maitland Cancer Appeal Committee
| Project Team | ||
|---|---|---|
| Professor Phil Hansbro, Professor Paul Foster, Doctor Gough Au | ||
| Scheme | Role | |
| Research Project | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $50,000 | 2011 | 2011 |
| GNo:G1100246 | ||
SCIREQ FlexiVentFX system + FlexiVentFX extension$45,000
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team | ||
|---|---|---|
| Professor Phil Hansbro, Professor Paul Foster, Professor Joerg Mattes, Doctor Simon Keely, Doctor Jay Horvat, Doctor Nicole Hansbro, Doctor Ming Yang, Doctor Catherine Ptaschinski, Doctor Kelly Asquith, Doctor Gough Au, Conjoint Associate Professor Peter Wark, Laureate Professor John Aitken, Conjoint Professor Keith Jones, Professor Roger Smith, Professor Judith Black, Professor Rakesh Kumar, Professor Paul Hertzog | ||
| Scheme | Role | |
| Equipment Grant | Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $45,000 | 2011 | 2011 |
| GNo:G1100037 | ||
World Cancer Congress 2011, World Expo Center, Dalian, China, 22 - 25 May 2011$1,500
Funding Body: University of Newcastle - Faculty of Health
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| Travel Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $1,500 | 2011 | 2012 |
| GNo:G1100576 | ||
2010 (1 grants)
Control of malignant glioma by naturally occurring oncolytic enteroviruses.$85,188
Funding Body: Cancer Australia
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| Priority-driven Collaborative Cancer Research | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $85,188 | 2010 | 2011 |
| GNo:G0190325 | ||
2009 (2 grants)
The use of Coxsackievirus A21 as a therapy for multiple myeloma and malignant glioma$30,000
Funding Body: Ramaciotti Foundations
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| Establishment Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $30,000 | 2009 | 2009 |
| GNo:G0189325 | ||
5th International Meeting on Replicating Oncolytic Virus Therapeutics, Banff Canada, 18-21 March 2009$1,700
Funding Body: University of Newcastle - Faculty of Health
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| Travel Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $1,700 | 2009 | 2009 |
| GNo:G0189949 | ||
2008 (1 grants)
New Staff Grant$5,379
Funding Body: University of Newcastle
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| New Staff Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $5,379 | 2008 | 2008 |
| GNo:G0188610 | ||
2007 (2 grants)
Coxsackievirus A21 virotherapy of multiple myeloma and malignant glioma$369,000
Funding Body: NHMRC (National Health & Medical Research Council)
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| Industry Research Fellowships | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $369,000 | 2007 | 2010 |
| GNo:G0186779 | ||
The use of Coxsackie B group viruses as potential treatments for human gastric and colorectal cancers$8,007
Funding Body: University of Newcastle
| Project Team | ||
|---|---|---|
| Doctor Gough Au | ||
| Scheme | Role | |
| Early Career Researcher Grant | Chief Investigator | |
| Total Amount | Funding Start | Funding Finish |
| $8,007 | 2007 | 2007 |
| GNo:G0188074 | ||
Research Supervision
| Number of current supervisions | 4 |
|---|---|
| Total current UoN PhD EFTSL | 2.05 |
For supervisions undertaken at an institution other that the University of Newcastle, details are shown in italics, and the institution name is listed below the program name.
Current Supervision
| Commenced | Proposed Completion | Program | Supervisor Type | Research Title |
|---|---|---|---|---|
| 2012 | 2016 | PhD (Immunology & Microbiol) | Co-Supervisor | Investigation of MicroRNAs, Epigenetic Changes and other Factors in the Development and Progression of Lung Cancer |
| 2011 | 2015 | PhD (Immunology & Microbiol) | Principal Supervisor | Combination of Oncolytic Coxsackievirus A21 with Conventional Chemotherapy for the Treatment of Melanoma |
| 2011 | 2015 | PhD (Immunology & Microbiol) | Principal Supervisor | Investigation of Oncolytic Coxsackievirus A21 as a Potential Treatment for Lung Cancer |
| 2010 | 2014 | PhD (Immunology & Microbiol) | Principal Supervisor | Low Pathogenic Human Enteroviruses as Novel Anti-Cancer Agents Against Human Malignant Glioma |
Dr Gough Au
| Work Phone | (02) 404 20253 |
|---|---|
| Fax | (02) 404 20027 |
| Gough.Au@newcastle.edu.au | |
| Position | Conjoint Fellow Viralytics School of Biomedical Sciences and Pharmacy Faculty of Health and Medicine |
| Focus Area | Immunology and Microbiology |
| Office | 2420, HMRI building, Level 2, HMRI Building East Wing |
| URL: | www.newcastle.edu.au/profile/gough-au |
| Link | http://www.mendeley.com/profiles/gough-au/ |
